CARSTEN BOESS

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CARSTEN BOESS:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 30,000 $73,518 $2.45 18 Jun 2025 Direct
Avidity Biosciences, Inc. Director Common Stock 0 $0 $72.51 27 Feb 2026 Direct
Atrium Therapeutics, Inc. Director Common Stock 11,005 26 Feb 2026 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 27 Feb 2026 Direct

Insider Reports Filed by CARSTEN BOESS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNA Avidity Biosciences, Inc. 27 Feb 2026 7 $0 4 Director 27 Feb 2026, 14:50
/report/000119312526077764-boess-carsten-2026-02-26 Atrium Therapeutics, Inc. 26 Feb 2026 0 $0 3 Director 26 Feb 2026, 18:16
RCKT ROCKET PHARMACEUTICALS, INC. 18 Jun 2025 1 $0 4 Director 18 Jul 2025, 16:05
RNA Avidity Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 18:40
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:10
RNA Avidity Biosciences, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 19:01
RCKT ROCKET PHARMACEUTICALS, INC. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 19:47
RNA Avidity Biosciences, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:01
RNA Avidity Biosciences, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:44
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 21:07
RNA Avidity Biosciences, Inc. 16 Jun 2021 1 $0 4 Director 16 Jun 2021, 19:59
RCKT ROCKET PHARMACEUTICALS, INC. 14 Jun 2021 1 $0 4 Director 16 Jun 2021, 20:07